TRDA NASDAQ
Entrada Therapeutics, Inc.
1W: -12.7%
1M: -26.3%
3M: -28.6%
YTD: -46.5%
1Y: -8.5%
3Y: -65.3%
$5.38
-0.30 (-5.28%)
Weekly Expected Move ±9.6%
$4
$5
$5
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$5M
Revenue
-94.1% YoY
$-166M
Net Income
-126.0% YoY
$-134M
Free Cash Flow
-6.2% YoY
100.0%
Gross Margin
-5007.0%
Op. Margin
-4762.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-54.1%
ROA-44.3%
ROIC-236.6%
Valuation
P/E-1.4
P/B1.0
EV/EBITDA-0.8
Leverage
Debt/Equity0.21
Current Ratio10.89
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z0.23
Beneish M-3.24